ADPT
Adaptive Biotechnologies Corporation
NASDAQ · USHealthcareBiotechnology
$21.86-4.62%
Price as of Jul 20, 2026
ADPT capital
Adaptive Biotechnologies Corporation capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- 0.96x
- Net debt / equity
- 0.60x
- Debt / assets
- 0.41x
- Debt / EBITDA
- -9.45x
- Net debt / EBITDA
- -5.93x
Liquidity & coverage
- Current ratio
- 3.35x
- Quick ratio
- 3.22x
- Cash ratio
- 2.51x
- Interest coverage
- -3.97x
- EBITDA / interest
- -1.87x
- Working capital
- $204.8M
Cash & dividend
- FCF / debt
- -0.14x
- Cash flow / debt
- -0.13x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.